This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. (VRTX) rose 1.37% to $452.04 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index  falling 1.07% to 6,827.41 and Dow Jones Industrial Average  falling 0.51% to 48,458.05.
This was the stock's third consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 13.02% below its 52-week high of $519.68, which the company achieved on March 14th.
The stock outperformed some of its competitors Friday, as AbbVie Inc. (ABBV) fell 0.29% to $223.32, Krystal Biotech Inc. (KRYS) fell 0.86% to $244.65, and Arcturus Therapeutics Holdings Inc. (ARCT) fell 0.80% to $7.46.
Trading volume (1.6 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 12, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-12-25 1637ET

VRTX

<p>Vertex Pharmaceuticals Inc. (VRTX) shares rose 1.37% to $452.04, outperforming competitors during a rough trading session where the S&P 500 and Dow Jones fell. This marks the third consecutive day of gains for Vertex, which remains 13.02% below its 52-week high. Trading volume was higher than the 50-day average.</p>

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day